256 related articles for article (PubMed ID: 28196277)
1. Factors predicting pain and effect of oral analgesia in topical photodynamic therapy.
Hambly RA; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ
Photodermatol Photoimmunol Photomed; 2017 May; 33(3):176-179. PubMed ID: 28196277
[No Abstract] [Full Text] [Related]
2. Photodynamic therapy of non-melanoma skin cancer with methyl aminolaevulinate is associated with less pain than with aminolaevulinic acid.
Gaál M; Otrosinka S; Baltás E; Ocsai H; Oláh J; Kemény L; Gyulai R
Acta Derm Venereol; 2012 Mar; 92(2):173-5. PubMed ID: 22113788
[No Abstract] [Full Text] [Related]
3. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
4. Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation.
Downs AM; Bower CB; Oliver DA; Stone CA
Br J Dermatol; 2009 Jul; 161(1):189-90. PubMed ID: 19416229
[No Abstract] [Full Text] [Related]
5. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
Ibbotson SH; Valentine R; Hearn R
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
[TBL] [Abstract][Full Text] [Related]
6. Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer.
Borroni RG; Carugno A; Rivetti N; Arbustini E; Brazzelli V
Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):73-7. PubMed ID: 23458390
[TBL] [Abstract][Full Text] [Related]
7. Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation.
Kolde G; Rowe E; Meffert H
Br J Dermatol; 2013 Feb; 168(2):450-2. PubMed ID: 22804095
[No Abstract] [Full Text] [Related]
8. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Morton CA
Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
[TBL] [Abstract][Full Text] [Related]
9. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
[TBL] [Abstract][Full Text] [Related]
10. European guidelines for topical PDT part 1 JEADV 2013; 27: 536-544.
Skaria AM
J Eur Acad Dermatol Venereol; 2014 May; 28(5):673. PubMed ID: 23981061
[No Abstract] [Full Text] [Related]
11. Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: optimizing patient selection.
Hambly R; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ
Br J Dermatol; 2017 Sep; 177(3):e55-e57. PubMed ID: 28028807
[No Abstract] [Full Text] [Related]
12. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
13. Response to Letter to the editor: 'European guidelines for topical PDT part 1. JEADV 2013;27:536-544' DOI: 10.1111/jdv.12258.
Morton CA; Szeimies RM; Sidoroff A; Braathen LR
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1451-2. PubMed ID: 24666245
[No Abstract] [Full Text] [Related]
14. Rapid development of squamous cell carcinoma after photodynamic therapy.
Liang WM; Theng TS; Lim KS; Tan WP
Dermatol Surg; 2014 May; 40(5):586-8. PubMed ID: 24858258
[No Abstract] [Full Text] [Related]
15. A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer.
Zeitouni NC; Paquette AD; Housel JP; Shi Y; Wilding GE; Foster TH; Henderson BW
Lasers Surg Med; 2013 Feb; 45(2):89-94. PubMed ID: 23390058
[TBL] [Abstract][Full Text] [Related]
16. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing pain and efficacy of topical photodynamic therapy: a retrospective study.
Lydon E; Dawe RS; Ibbotson SH
Br J Dermatol; 2019 Jan; 180(1):205-206. PubMed ID: 30216404
[No Abstract] [Full Text] [Related]
18. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.
Morton CA; Szeimies RM; Sidoroff A; Braathen LR
J Eur Acad Dermatol Venereol; 2013 May; 27(5):536-44. PubMed ID: 23181594
[TBL] [Abstract][Full Text] [Related]
19. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
20. [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
Basset-Seguin N
Ann Dermatol Venereol; 2013 Nov; 140 Suppl 2():223-8. PubMed ID: 24199714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]